Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl G Helmer

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Aging and Disease|June 12, 2023
Cross-Vendor Test-Retest Validation of Diffusion Tensor Image Analysis along the Perivascular Space (DTI-ALPS) for Evaluating Glymphatic System FunctionXiaodan Liu, Giuseppe Barisano, Xingfeng Shao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
MRI free water mediates the association between diffusion tensor image analysis along the perivascular space and executive function in four independent middle to aged cohortsXiaodan Liu, Pauline Maillard, Giuseppe Barisano, et al.
Eclinicalmedicine|June 13, 2025
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trialÁngeles García-Cazorla, Caroline Sevin, Juliana Ribeiro Constante, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2022
Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kitsPauline Maillard, Hanzhang Lu, Konstantinos Arfanakis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 16, 2022
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortiumPauline Maillard, Laura J Hillmer, Hanzhang Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2024
Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID ConsortiumPeiying Liu, Zixuan Lin, Kaisha Hazel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocolsDonna Wilcock, Gregory Jicha, Deborah Blacker, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2023
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression ProtocolAhmed A Bahrani, Erin L Abner, Charles S DeCarli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2024
Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID ConsortiumAlison M Luckey, Saptaparni Ghosh, Chen-Pin Wang, et al.
Annals of Neurology|September 22, 2025
MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline CharacteristicsSteven M Greenberg, Marylin S Albert, Hongyu An, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Aging and Disease|June 12, 2023
Cross-Vendor Test-Retest Validation of Diffusion Tensor Image Analysis along the Perivascular Space (DTI-ALPS) for Evaluating Glymphatic System FunctionXiaodan Liu, Giuseppe Barisano, Xingfeng Shao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
MRI free water mediates the association between diffusion tensor image analysis along the perivascular space and executive function in four independent middle to aged cohortsXiaodan Liu, Pauline Maillard, Giuseppe Barisano, et al.
Eclinicalmedicine|June 13, 2025
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trialÁngeles García-Cazorla, Caroline Sevin, Juliana Ribeiro Constante, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2022
Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kitsPauline Maillard, Hanzhang Lu, Konstantinos Arfanakis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 16, 2022
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortiumPauline Maillard, Laura J Hillmer, Hanzhang Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2024
Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID ConsortiumPeiying Liu, Zixuan Lin, Kaisha Hazel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocolsDonna Wilcock, Gregory Jicha, Deborah Blacker, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2023
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression ProtocolAhmed A Bahrani, Erin L Abner, Charles S DeCarli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2024
Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID ConsortiumAlison M Luckey, Saptaparni Ghosh, Chen-Pin Wang, et al.
Annals of Neurology|September 22, 2025
MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline CharacteristicsSteven M Greenberg, Marylin S Albert, Hongyu An, et al.
Pageof 5